Catalysis can significantly improve the efficiency and specificity of immunotherapy. Catalysts can be engineered to activate or deactivate immune cells, modulate the tumor microenvironment, or deliver therapeutic agents with high precision. By enhancing reaction rates and targeting specific pathways, catalysis helps in achieving better clinical outcomes in immunotherapy.
